Pamela Wapnick
CFO at Metagenomi Therapeutics, Inc. (MGX); CFO at Metagenomi, Inc. (MGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $14K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 10SEC | MGXMetagenomi Therapeutics, Inc. | Sell | 1,911206,580 held (−1%) | $1.16 | $2K | -13.8% |
| Jun 10SEC | MGXMetagenomi Therapeutics, Inc. | Sell | 2,884208,491 held (−1%) | $1.30 | $4K | -23.1% |
| Mar 9SEC | MGXMetagenomi Therapeutics, Inc. | Sell | 1,581187,375 held (−1%) | $1.60 | $3K | -37.5% |
| Dec 8SEC | MGXMetagenomi, Inc. | Sell | 1,576188,956 held (−1%) | $1.77 | $3K | -43.5% |
| Dec 1SEC | MGXMetagenomi, Inc. | Sell | 1,57670,532 held (−2%) | $1.81 | $3K | -44.8% |